Wordt geladen...

Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer

PURPOSE: The independent predictive information from progesterone receptor (PgR) positivity for breast cancer treated with tamoxifen has been questioned after an overview by the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). However, the studies in the overview were to a large content...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Breast Cancer Res Treat
Hoofdauteurs: Nordenskjöld, Anna, Fohlin, Helena, Fornander, Tommy, Löfdahl, Britta, Skoog, Lambert, Stål, Olle
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer US 2016
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5065613/
https://ncbi.nlm.nih.gov/pubmed/27722840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-4007-5
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!